<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-21T00:35:19Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/284402" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/284402</identifier><datestamp>2021-04-21T19:03:34Z</datestamp><setSpec>com_1810_721</setSpec><setSpec>com_1810_256064</setSpec><setSpec>col_1810_218856</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Metal Mediated Mechanisms of Drug Release</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">10.17863/CAM.31775</dc:identifier>
   <dc:creator>Stenton, Benjamin James</dc:creator>
   <uketdterms:authoridentifier xsi:type="uketdterms:ORCID">0000000158522803</uketdterms:authoridentifier>
   <uketdterms:advisor>Bernardes, Goncalo</uketdterms:advisor>
   <uketdterms:authoridentifier xsi:type="uketdterms:ORCID">0000000165948917</uketdterms:authoridentifier>
   <dcterms:abstract>In this thesis will be described research towards the development of bioorthogonal bond-cleavage reactions, and their applications in targeted drug delivery (Figure 1). The first project relates to the development of a palladium mediated bond-cleavage or “decaging” reaction which can cause a propargyl carbamate to decompose and release an amine. This was further developed by the incorporation of a protein modification handle which allowed an amine-bearing drug to be covalently ligated to a protein by a palladium-cleavable linker. This chemistry was demonstrated by the conjugation of the anticancer drug doxorubicin to a tumour targeted anti-HER2 nanobody. The drug could then be delivered to cancer cells upon addition of a palladium complex.

The second project relates to the development of a platinum mediated bond-cleavage reaction. This was developed with the aim of using platinum-containing anticancer drugs – such as cisplatin – as a catalyst to cause drug release reactions in tumours. In this reaction an alkyne-containing amide can decompose to release an amine upon addition of platinum complexes, and was applied to the release of prodrugs of the cytotoxins monomethylauristatin E and 5-fluorouracil in cancer cells. A cisplatin-cleavable antibody-drug conjugate was designed and synthesised, and progress towards its biological evaluation will be discussed.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2018-11-24</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>en</dc:language>
   <uketdterms:sponsor>EPSRC</uketdterms:sponsor>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/284402</dcterms:isReferencedBy>
   <dc:identifier xsi:type="dcterms:URI">https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/d244ea95-88b6-480e-9da4-a3fdf49165bb/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">18a3c77b2086660b3c509fb6cda26601</uketdterms:checksum>
   <dcterms:license>https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/1e3327de-029f-427c-adf6-f66f05c54c4b/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>https://www.rioxx.net/licenses/all-rights-reserved/</dc:rights>
   <dc:subject>Bioorthogonal</dc:subject>
   <dc:subject>decaging</dc:subject>
   <dc:subject>linker</dc:subject>
   <dc:subject>ADC</dc:subject>
   <dc:subject>antibody-drug conjugate</dc:subject>
   <dc:subject>targeted drug delivery</dc:subject>
   <dc:subject>drug delivery</dc:subject>
   <dc:subject>bifunctional linker</dc:subject>
   <dc:subject>protein modification</dc:subject>
   <dc:subject>organometallic</dc:subject>
   <dc:subject>catalysis</dc:subject>
   <dc:subject>chemotherapy</dc:subject>
   <dc:subject>cancer</dc:subject>
   <dc:subject>bioconjugation</dc:subject>
   <dc:subject>conjugation</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>